Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 07, 2017
Co-Diagnostics and Synbiotics announced CoSara Diagnostics, a Joint Venture for manufacturing, has broken ground for its manufacturing facility in India.
read more
CoSara Diagnostics broke ground on the future Good Manufacturing Practices (GMP) facility in October 2017.
read more
Tuesday, February 04, 2020
CNS has completed the final GMP manufacturing run of its lead candidate Berubicin, which it acquired from Reata and the GMP material has met all specifications.
read more
Thursday, October 22, 2020
CNS announced the Company's U.S. manufacturer, Pii, has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for GBM.
read more
Tuesday, November 26, 2019
CNS has entered into a sublicense agreement with WPD, a Polish corporation partially owned and controlled by Dr. Waldemar Priebe, the founder of the Company.
read more
Tuesday, January 28, 2020
CNS announced Anthem Biosciences of Bangalore, India has completed a pilot run of the recrystallization of the Reata Pharmaceuticals API.
read more
CMP Pharma announced the FDA has granted final approval of the company’s New Drug Application for CaroSpir.
read more
Wednesday, November 13, 2019
CMIC CMO USA, a contract manufacturer serving the pharmaceutical industry, has committed to a 233,000-square-foot property in Cranbury, New Jersey.
read more
Tuesday, December 12, 2017
CMC ICOS Biologics and Harpoon Therapeutics have entered into an agreement for the development and manufacturing of HPN424, HPN536, and HPN217.
read more
CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, today announced that it has hired Patricio E. Massera to serve as the Company’s new General Manager for its ...
read more
Tuesday, December 29, 2015
CMC Biologics, Inc. today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process ...
read more
CMC Biologics, Inc., a global leader in process development and contract
manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal antibody-based ...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based ...
read more
Wednesday, September 04, 2019
CMAB Biopharma and Kintor announced a comprehensive strategic cooperation agreement for the development and manufacturing of ALK-1 monoclonal antibody (mAb).
read more
Monday, December 09, 2019
CMAB Biopharma and Shenzhen Fapon Biopharma announced a comprehensive strategic agreement for the development and manufacturing of an undisclosed biologic drug project.
read more